ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression

ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression

Bibliographic Details
Main Authors:	Chen Xue, Xinyu Gu, Qiuxian Zheng, Qingmiao Shi, Xin Yuan, Yuanshuai Su, Junjun Jia, Jianwen Jiang, Juan Lu, Lanjuan Li
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-03-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-023-01395-7

Similar Items

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
by: Chen Xue, et al.
Published: (2022-09-01)

The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
by: Chen Xue, et al.
Published: (2024-03-01)

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
by: Chen Xue, et al.
Published: (2022-10-01)

Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications
by: Qingmiao Shi, et al.
Published: (2023-12-01)

Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A scRNA‐Seq Analysis
by: Chen Xue, et al.
Published: (2023-06-01)

LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling
by: Qiurong Yang, et al.
Published: (2023-08-01)

Integrated bioinformatics analysis reveals the function and prognostic value of OSBPL3 in hepatocellular carcinoma
by: Yuanshuai Su, et al.
Published: (2023-06-01)

A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes
by: Qingmiao Shi, et al.
Published: (2023-06-01)

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes
by: Qingmiao Shi, et al.
Published: (2023-05-01)

NSUN2-mediated mRNA m5C Modification Regulates the Progression of Hepatocellular Carcinoma
by: Dan Song, et al.
Published: (2023-08-01)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
by: Yuanshuai Su, et al.
Published: (2023-05-01)

The role of RNA modification in hepatocellular carcinoma
by: Qiang Feng, et al.
Published: (2022-09-01)

Functions and underlying mechanisms of miR-650 in human cancers
by: Yuanshuai Su, et al.
Published: (2022-03-01)

Development of a promising PPAR signaling pathway-related prognostic prediction model for hepatocellular carcinoma
by: Qingmiao Shi, et al.
Published: (2024-02-01)

ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion
by: Qingbo Meng, et al.
Published: (2024-02-01)

PTBP1 promotes hepatocellular carcinoma progression by regulating the skipping of exon 9 in NUMB pre-mRNA
by: Zhentao He, et al.
Published: (2023-06-01)

LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma
by: Houhong Wang, et al.
Published: (2023-03-01)

Health and Disease: Akkermansia muciniphila, the Shining Star of the Gut Flora
by: Chen Xue, et al.
Published: (2023-01-01)

Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis
by: Nanfang Qu, et al.
Published: (2020-02-01)

CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma
by: Ying Huang, et al.
Published: (2023-08-01)

Circular RNA circ_0008274 upregulates granulin to promote the progression of hepatocellular carcinoma via sponging microRNA -140-3p
by: Chanchan Gao, et al.
Published: (2021-01-01)

Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA–mRNA network and signature analysis
by: Fei Wang, et al.
Published: (2024-02-01)

m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization
by: Ning Wang, et al.
Published: (2023-02-01)

Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer
by: Yujie Yuan, et al.
Published: (2024-03-01)

Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma
by: Kailiang Qiao, et al.
Published: (2023-12-01)

UTP11 promotes the growth of hepatocellular carcinoma by enhancing the mRNA stability of Oct4
by: Yan Chen, et al.
Published: (2024-01-01)

N6-methyladenosine (m6A) modification in hepatocellular carcinoma
by: Hehua Ma, et al.
Published: (2024-04-01)

THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification
by: Tao Yu, et al.
Published: (2023-07-01)

hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
by: Weijie Hao, et al.
Published: (2023-11-01)

Progress of vimentin in hepatocellular carcinoma
by: DONG Bao-long, HAN Cai-wen, SHI Ming, ZHENG Wen-xue, YANG Xiao-jun
Published: (2020-02-01)

CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA
by: Chenwei Tang, et al.
Published: (2024-03-01)

m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression
by: Hua Liu, et al.
Published: (2023-12-01)

ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis
by: Hongwei Zhang, et al.
Published: (2022-11-01)

CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure
by: Tushuai Li, et al.
Published: (2023-04-01)

Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients
by: Anum Syyam, et al.
Published: (2023-02-01)

Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
by: Yiwei Xu, et al.
Published: (2023-01-01)

Analysis of eight types of RNA modification regulators and their correlation with the prognosis in hepatocellular carcinoma
by: Wan Qin, et al.
Published: (2023-03-01)

Integrated Analysis of Altered lncRNA, circRNA, microRNA, and mRNA Expression in Hepatocellular Carcinoma Carrying TERT Promoter Mutations
by: Zhang H, et al.
Published: (2022-11-01)

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
by: Lisha Zhou, et al.
Published: (2023-07-01)

LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2
by: Fan Wang, et al.
Published: (2023-10-01)